Listeria Epitopes TCR Transgenics Antigen Sensitivity and Early Signaling
Listeria Epitopes TCR Transgenics Antigen Sensitivity and Early Signaling
批准号:
7679656
负责人:
Mark Morris Davis
金额:
$33.5万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AgonistAntigensArtsAvidityBiochemistryBiological AssayBiological ModelsBlast CellCD4 Positive T LymphocytesCalciumCellsCellular ImmunityCellular ImmunologyCellular biologyClassCompatibleDataDevelopmentDimerizationEpitopesEventGoalsHistocompatibility Antigens Class IIImageImmune responseImmunityImmunocompromised HostIn VitroInfectionInterferonsInterleukin-2LaboratoriesLigandsListeriaListeria monocytogenesListeriosisMHC Class I GenesMHC Class II GenesMacrophage ActivationMature T-LymphocyteMemoryModelingMolecularMusNatural Killer CellsNumbersOvalbuminOvumPeptide/MHC ComplexPeptidesProductionProliferatingPropertyReagentResearch PersonnelRoleRole playing therapySensitivity and SpecificitySeriesSignal TransductionStagingT memory cellT-Cell ActivationT-Cell ReceptorT-LymphocyteTechniquesTestingTimeTransgenic MiceTransgenic OrganismsVirulenceWeekWorkcomputer studiesdayexperienceinsightinterestkillingsmembrane modelpathogenprogramsresearch studyresponsesingle moleculesynaptogenesis
中文摘要
在过去的30年左右,T细胞对“模型”抗原的反应的深入研究已经产生了大量的结果。
深入了解T细胞生物学和功能,特别是当它涉及到特定的肽-MHC的识别
复合物通过T细胞受体抗原。
与该项目特别相关的是,现在有很好的证据表明,成熟的T细胞母细胞对
即使是单个分子的激动剂(肽-MHC)配体,这种非凡的敏感性至少在
通过特定的内源性肽-MHC复合物与免疫球蛋白的结合而实现的飞镖。
激动剂触发TCR二聚化。我们现在希望将这些研究扩展到CD 4和CDS的分析。
李斯特菌感染过程中不同时间和不同发育阶段的T细胞反应性
单核细胞增多症感染小鼠。
我们特别希望检验这样一个假设,即在李斯特菌感染过程中占优势的T细胞,
这是因为它们具有优良的上级信号特性。
这些研究将涉及制备一系列对李斯特菌LLO表位具有特异性的CD 4转基因物,
检测这些转基因细胞的敏感性和保护能力。该项目将涉及
高度定量的实验数据和最先进的建模技术之间的密切联系。
英文摘要
In the past 30 years or so, intensive work on T cell responses to 'model' antigens has resulted in a great deal
of insight into T cell biology and function, particularly as it relates to the recognition of specific peptide-MHC
complexes through the T cell receptor for antigen.
Of particular relevance to this project, there is now good evidence that mature T cell blasts are sensitive to
even a single molecule of an agonist (peptide-MHC) ligand and that this extraordinary sensitivity is at least in
Dart achieved by the engagement of particular endogenous peptide-MHC complexes together with the
agonist in triggering TCR dimerization. We now wish to extend these studies to the analysis of CD4 and CDS
T cell responsiveness as different times and with different developmental stages of T cells during Listeria
monocytogenes infection in mice.
We particularly wish to test the hypothesis that T cells which emerge as dominant during Listeria infection do
so because they have superior signaling properties.
These studies will involve making a series of CD4transgenics specific for a Listeria LLO epitope and
assaying these transgenic cells for sensitivity and ability to be protective throughout. This project will involve
the close interfacing between highly quantitative experimental data and state of the art modeling techniques.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Systems biological assessment of T cell responses to vaccination
-
批准号:10584571
-
项目类别:
-
资助金额:$37.9万
-
财政年份:2022
-
负责人:Mark Morris Davis
-
依托单位:
Systems biological assessment of T cell responses to vaccination
-
批准号:10419280
-
项目类别:
-
资助金额:$30.97万
-
财政年份:2022
-
负责人:Mark Morris Davis
-
依托单位:
Administrative Core
-
批准号:10190558
-
项目类别:
-
资助金额:$6.62万
-
财政年份:2021
-
负责人:Mark Morris Davis
-
依托单位:
Molecular interception and immunological characterization of age-associated disease
-
批准号:10190562
-
项目类别:
-
资助金额:$63.87万
-
财政年份:2021
-
负责人:Mark Morris Davis
-
依托单位:
High resolution longitudinal immune monitoring for elucidating immune aging dynamics
-
批准号:10190557
-
项目类别:
-
资助金额:$370.0万
-
财政年份:2021
-
负责人:Mark Morris Davis
-
依托单位:
Administrative Core
-
批准号:10687220
-
项目类别:
-
资助金额:$16.43万
-
财政年份:2021
-
负责人:Mark Morris Davis
-
依托单位:
High resolution longitudinal immune monitoring for elucidating immune aging dynamics
-
批准号:10491673
-
项目类别:
-
资助金额:$350.0万
-
财政年份:2021
-
负责人:Mark Morris Davis
-
依托单位:
Administrative Core
-
批准号:10491674
-
项目类别:
-
资助金额:$14.47万
-
财政年份:2021
-
负责人:Mark Morris Davis
-
依托单位:
High resolution longitudinal immune monitoring for elucidating immune aging dynamics
-
批准号:10687219
-
项目类别:
-
资助金额:$350.0万
-
财政年份:2021
-
负责人:Mark Morris Davis
-
依托单位:
Molecular interception and immunological characterization of age-associated disease
-
批准号:10687228
-
项目类别:
-
资助金额:$74.66万
-
财政年份:2021
-
负责人:Mark Morris Davis
-
依托单位:
Molecular interception and immunological characterization of age-associated disease
-
批准号:10491684
-
项目类别:
-
资助金额:$106.48万
-
财政年份:2021
-
负责人:Mark Morris Davis
-
依托单位:
Project 3: T Cells
-
批准号:10688369
-
项目类别:
-
资助金额:$34.48万
-
财政年份:2020
-
负责人:Mark Morris Davis
-
依托单位:
Influenza responses and repertoire in vaccination, infection and tonsil organoids.
-
批准号:10265695
-
项目类别:
-
资助金额:$175.38万
-
财政年份:2020
-
负责人:Mark Morris Davis
-
依托单位:
Project 3: T Cells
-
批准号:10222107
-
项目类别:
-
资助金额:$93.92万
-
财政年份:2020
-
负责人:Mark Morris Davis
-
依托单位:
Administrative and Clinical Core
-
批准号:8306399
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2011
-
负责人:Mark Morris Davis
-
依托单位:
T cell responses to H1N1 and a longitudinal study of seasonal flu vaccination
-
批准号:8306394
-
项目类别:
-
资助金额:$22.62万
-
财政年份:2011
-
负责人:Mark Morris Davis
-
依托单位:
Pilot Projects Core
-
批准号:8306400
-
项目类别:
-
资助金额:$9.72万
-
财政年份:2011
-
负责人:Mark Morris Davis
-
依托单位:
Vaccination and infection: indicators of immunological health and responsiveness
-
批准号:8303264
-
项目类别:
-
资助金额:$308.75万
-
财政年份:2010
-
负责人:Mark Morris Davis
-
依托单位:
Vaccination and infection: indicators of immunological health and responsiveness
-
批准号:8509587
-
项目类别:
-
资助金额:$290.88万
-
财政年份:2010
-
负责人:Mark Morris Davis
-
依托单位:
Vaccination and infection: indicators of immunological health and responsiveness
-
批准号:7978139
-
项目类别:
-
资助金额:$457.98万
-
财政年份:2010
-
负责人:Mark Morris Davis
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: